Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chandrika Jeyamohan

1PUBLICATIONS

19CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 13, 2024

Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.

Jason J Luke, Karen Gelmon, Lillian L Siu

Pageof 1

Frequent Collaborators

1 joint publications

Jason J Luke

1 joint publications

Karen Gelmon

1 joint publications

Lillian L Siu

1 joint publications

Victor Moreno

1 joint publications

Jayesh Desai

1 joint publications

Carlos A Gomez-Roca

1 joint publications

Matteo S Carlino

1 joint publications

Russell K Pachynski

1 joint publications

Rasha Cosman

1 joint publications

Quincy Siu-Chung Chu

Frequent Collaborators

1 joint publications

Jason J Luke

1 joint publications

Karen Gelmon

1 joint publications

Lillian L Siu

1 joint publications

Victor Moreno

Top Related Videos

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

See more related videos

Top Related Videos

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

See more related videos